Literature DB >> 26523883

Age, Gender and R.E.N.A.L. Nephrometry Score do not Improve the Accuracy of a Risk Stratification Algorithm Based on Biopsy and Mass Size for Assigning Surveillance versus Treatment of Renal Tumors.

Takahiro Osawa1, Khaled S Hafez1, David C Miller1, Jeffrey S Montgomery1, Todd M Morgan1, Ganesh S Palapattu1, Alon Z Weizer1, Elaine M Caoili2, James H Ellis2, Lakshmi P Kunju3, J Stuart Wolf4.   

Abstract

PURPOSE: A previously published risk stratification algorithm based on renal mass biopsy and radiographic mass size was useful to designate surveillance vs the need for immediate treatment of small renal masses. Nonetheless, there were some incorrect assignments, most notably when renal mass biopsy indicated low risk malignancy but final pathology revealed high risk malignancy. We studied other factors that might improve the accuracy of this algorithm.
MATERIALS AND METHODS: For 202 clinically localized small renal masses in a total of 200 patients with available R.E.N.A.L. (radius, exophytic/endophytic, nearness of tumor to collecting system or sinus, anterior/posterior, hilar tumor touching main renal artery or vein and location relative to polar lines) nephrometry score, preoperative renal mass biopsy and final pathology we assessed the accuracy of management assignment (surveillance vs treatment) based on the previously published risk stratification algorithm as confirmed by final pathology. Logistic regression was used to determine whether other factors (age, gender, R.E.N.A.L. score, R.E.N.A.L. score components and nomograms based on R.E.N.A.L. score) could improve assignment.
RESULTS: Of the 202 small renal masses 53 (26%) were assigned to surveillance and 149 (74%) were assigned to treatment by the risk stratification algorithm. Of the 53 lesions assigned to surveillance 25 (47%) had benign/favorable renal mass biopsy histology while in 28 (53%) intermediate renal mass biopsy histology showed a mass size less than 2 cm. Nine of these 53 masses (17%) were incorrectly assigned to surveillance in that final pathology indicated the need for treatment (ie intermediate histology and a mass greater than 2 cm or unfavorable histology). Final pathology confirmed a correct assignment in all 149 masses assigned to treatment. None of the additional parameters assessed improved assignment with statistical significance.
CONCLUSIONS: Age, gender, R.E.N.A.L. nephrometry score, R.E.N.A.L. score components and nomograms or combinations of these factors do not improve the predictive performance of a small renal mass management risk stratification algorithm based on renal mass biopsy and radiographic mass size.
Copyright © 2016 American Urological Association Education and Research, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  algorithms; biopsy; kidney neoplasms; prognosis; risk

Mesh:

Year:  2015        PMID: 26523883     DOI: 10.1016/j.juro.2015.10.137

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  4 in total

1.  [Watchful waiting and active surveillance of small renal masses].

Authors:  R Mager; S Frees; A Haferkamp
Journal:  Urologe A       Date:  2018-03       Impact factor: 0.639

Review 2.  Update on Renal Mass Biopsy.

Authors:  Miki Haifler; Alexander Kutikov
Journal:  Curr Urol Rep       Date:  2017-04       Impact factor: 3.092

3.  Active Surveillance for Small Renal Masses in Young Patients.

Authors:  Giovanni Cacciamani; Carlos Fay; Daniel Park; Mohammed Alotaibi; Inderbir S Gill
Journal:  Eur Urol Focus       Date:  2017-03-23

4.  Comparison of the Results of Therapy for cT1 Renal Carcinoma with Nephron-Sparing Surgery (NSS) vs. Percutaneous Thermal Ablation (TA).

Authors:  Michał Rusinek; Marek Salagierski; Waldemar Różański; Bartłomiej Jakóbczyk; Michał Markowski; Marek Lipiński; Jacek Wilkosz
Journal:  J Pers Med       Date:  2022-03-18
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.